CRYGC: A Tool for Cancer Research (G1420)

Target Name: CRYGC

NCBI ID: G1420

CRYGC

CRYGC: A Tool for Cancer Research

CRYGC (Cryogenic Extraction of Recoverable Yield) is a technique that is used to extract valuable compounds from tissues or cells that are cryoprotectively frozen and then thawed out. This technique is of particular interest as it can be used to extract compounds that are difficult to obtain from living cells, such as cancer cells.

One of the main advantages of CRYGC is its ability to selectively extract a specific compound or set of compounds from a frozen tissue or cell. This is achieved by using a cryoprotectant, which is a substance that helps to protect the tissue or cell from the cold and also allows it to be easily thawed out.

One of the challenges with CRYGC is the high cost of the necessary cryoprotectants, which can limit the availability of these techniques for research and clinical applications. However, there are ongoing efforts to develop more affordable alternatives to these cryoprotectants, which could lead to wider use of CRYGC.

Another potential drawback of CRYGC is the potential for the destruction of the tissue or cell during the extraction process. This is because the tissue or cell must be frozen and then thawed out, which can cause some damage to the cells. However, there are steps that can be taken to minimize this potential damage, such as using gentle handling techniques and carefully monitoring the thawing process.

Overall, CRYGC is a technique that has the potential to be a valuable drug target or biomarker. Its ability to selectively extract specific compounds from frozen tissues or cells makes it a useful tool for the study of a wide range of biological phenomena, including cancer. As the field of CRYGC continues to grow, it is likely that new applications and developments will emerge, making it an increasingly important area of research.

Protein Name: Crystallin Gamma C

Functions: Crystallins are the dominant structural components of the vertebrate eye lens

The "CRYGC Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CRYGC comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets